Clinical Trials Directory

Trials / Completed

CompletedNCT06212531

Papuan Indigenous Model of Male Circumcision

The Papuan Indigenous Model of Voluntary Clinical Male Circumcision

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
239 (actual)
Sponsor
University of Illinois at Chicago · Academic / Other
Sex
All
Age
15 Years – 70 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is: AIM 1: To engage Papuan community members to explore acceptability, barriers and facilitators for introducing a school-based age and culturally appropriate, comprehensive VMMC intervention to reduce HIV incidence in the Papuan population. AIM 2: To assess the capacity of the community health system to meet international criteria for safe comprehensive VMMC services and to ensure the availability of resources and training necessary to meet these criteria in selected clinics. AIM 3: To design the PIM of school-based adolescent VMMC based on information collected in Aims 1 and 2 and in consultation with a community advisory board, the Ministry of Health and the Ministry of Education. AIM 4: To pilot-test the school-based PIM Intervention of VMMC with 400 boys ages 12-18 years at two HIV high-risk Papuan locations: the Nabire and Jayapura. Primary outcomes are the proportion of adolescent males exposed to school-based PIM VMMC educational and informational sessions who get circumcised and surgical event safety. Secondary outcomes are satisfaction by adolescent males and parents, any sexual activity within 6 weeks after circumcision, changes in sexual risk behaviors between base-line and 12 weeks after circumcision, and perceptions of providers regarding MC training and implementation, ease of device use, and challenges encountered.

Conditions

Interventions

TypeNameDescription
PROCEDUREMedical male circumcision using standard surgical technique.Medical male circumcision using the WHO standard technique followed by examination of wound healing and behavioral risk assessment.

Timeline

Start date
2020-09-07
Primary completion
2023-08-31
Completion
2023-08-31
First posted
2024-01-19
Last updated
2024-01-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06212531. Inclusion in this directory is not an endorsement.